Phase 2 and pharmacodynamic study of oral forodesine in patients with advanced, fludarabine-treated chronic lymphocytic leukemia.
about
Plasmodium falciparum parasites are killed by a transition state analogue of purine nucleoside phosphorylase in a primate animal modelCatalytic site conformations in human PNP by 19F-NMR and crystallography.Enzymatic transition states, transition-state analogs, dynamics, thermodynamics, and lifetimesGold(I) complexes of 9-deazahypoxanthine as selective antitumor and anti-inflammatory agentsPreclinical and clinical evaluation of forodesine in pediatric and adult B-cell acute lymphoblastic leukemiaInfluence of bone marrow stromal microenvironment on forodesine-induced responses in CLL primary cells.Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome)Survival for older patients with acute myeloid leukemia: a population-based studyNew nucleoside analogs for patients with hematological malignancies.Transition States, analogues, and drug development.Apoptosis inducers in chronic lymphocytic leukemia.8-Azapurines as isosteric purine fluorescent probes for nucleic acid and enzymatic research.Differential expression pattern of protein markers for predicting chemosensitivity of dexamethasone-based chemotherapy of B cell acute lymphoblastic leukemia.Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancerImmucillin-H, a purine nucleoside phosphorylase transition state analog, causes non-lethal attenuation of growth in Staphylococcus aureus.
P2860
Q27314759-3BEAB213-F3B8-4F10-AB40-F0417289897AQ27676624-2E1F9656-6E0F-42A5-AEEC-A4A718112F66Q28240827-F749D05B-B0FC-44D9-9B4B-EC71EEE2D23FQ28543791-A9B08F01-C415-4457-A7A6-E3F99A8AC3C7Q33916091-7908A3C6-8E45-4692-A638-16A8048EAD84Q34122323-43C52C5A-2C63-483A-9C82-E1C82F13B858Q35022833-0824886D-EE9A-4CCD-8C82-537CF5BB5158Q36662052-D3426EBC-54D3-476A-B1C1-6743C1636980Q37841589-EF870776-95EE-453F-A902-103099CC43B2Q38069211-D46DF0FD-6D47-4EFD-87B0-4D350323645FQ38187815-37F46461-3325-407E-ABC5-BD0783E671F2Q38240046-0303CC8A-7AA0-43B9-AFCC-D2633E3BF39EQ38701181-F0089DEA-C5A7-4B31-8D58-3F4C5933DF59Q39446151-ADF18CCE-373C-4C07-9A7B-57B317612D73Q42118069-BC21E2AB-67B7-4807-83CC-56FEA84AA01E
P2860
Phase 2 and pharmacodynamic study of oral forodesine in patients with advanced, fludarabine-treated chronic lymphocytic leukemia.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Phase 2 and pharmacodynamic st ...... chronic lymphocytic leukemia.
@ast
Phase 2 and pharmacodynamic st ...... chronic lymphocytic leukemia.
@en
Phase 2 and pharmacodynamic st ...... chronic lymphocytic leukemia.
@nl
type
label
Phase 2 and pharmacodynamic st ...... chronic lymphocytic leukemia.
@ast
Phase 2 and pharmacodynamic st ...... chronic lymphocytic leukemia.
@en
Phase 2 and pharmacodynamic st ...... chronic lymphocytic leukemia.
@nl
prefLabel
Phase 2 and pharmacodynamic st ...... chronic lymphocytic leukemia.
@ast
Phase 2 and pharmacodynamic st ...... chronic lymphocytic leukemia.
@en
Phase 2 and pharmacodynamic st ...... chronic lymphocytic leukemia.
@nl
P2093
P2860
P50
P1433
P1476
Phase 2 and pharmacodynamic st ...... chronic lymphocytic leukemia.
@en
P2093
Brenita F Tyler
Dushyant Verma
John Michael Kilpatrick
Kumudha Balakrishnan
Shanta Bantia
Susan Bickel
Varsha Gandhi
Yuling Chen
P2860
P304
P356
10.1182/BLOOD-2010-02-272039
P407
P577
2010-04-28T00:00:00Z